The Dharma, sutras, and commentarial interpretations of interest to American Buddhists of all traditions with news that not only informs but transforms. Emphasis on meditation, enlightenment, karma, social evolution, and nonharming.
(To contact us, leave a comment marked "private").
Monday, April 7, 2025
Study psychedelics, ecstasy, drugs
Entheogenic medicinal substances must only be administered with "set and setting" in mind.
.
Who knows what patients might see when dosed
Ever think about studying psychedelics? Well, now it's possible because the California Institute of Integral Studies (CIIS) is offering the first accredited bachelor's degree of its kind in the United States.
Professor of Psychology Nick Walker at CIIS explained the new program on KCBS Radio the Bay Area, saying a lot of people are interested in psychedelics as an area of study.
He described the current situation as a psychotherapy renaissance when people are eager to test the use of drugs that act as hallucinogenicentheogenic potential-medicines.
"There's a lot of very exciting psychedelic research in terms of its potential as a [depression and] PTSD treatment, for instance. There's a lot of work happening with psychedelics, and we think it's very important that people approach it in a scientific fashion, in a well-informed fashion, in an ethically informed fashion.
"Because you know when something like this, when there's a big boom in something like psychedelics, some exciting method of treatment and exploration and personal growth, it can be kind of a Wild West scenario, with people experimenting wildly."
Psychedelics have gotten a lot of attention in popular culture recently, with claims they can assist people in the throes of a deep depression, help veterans and trauma survivors.
Okay, now I've gone too far. Stop the ride, please
A 2023 study by the National Institute of Health said PTSD currently affects an estimated 12 million U.S. adults and "initial clinical trials have demonstrated the potential value of psychedelic-assisted therapy to treat PTSD and other psychiatric disorders."
All materials on this site are submitted by editors and readers. All images, unless otherwise noted, were taken from the Internet and are assumed to be in the public domain.
In the event that there is still a problem, issue, or error with copyrighted material, the break of the copyright is unintentional and noncommercial, and the material will be removed immediately upon presented proof.
Contact us by submitting a comment marked "private."
Do not follow this journal if you are under vinaya or parental restrictions. Secure protection by Sucuri.
Wisdom Quarterly: American Buddhist Journal is licensed under a Creative Commons Attribution-Noncommercial-Share Alike 3.0 United States License. Permissions beyond the scope of this license may be available at creativecommons.org/about/licenses.
No comments:
Post a Comment